Merck Invests in Israeli Biotechnology

Monday, April 02, 2018 |  Ariel Rudolph

The German pharmaceutical company Merck, together with other international companies in the same line of business, plan to launch a fund that will invest 20 million euros ($24.6 million) in Israeli biotechnology over the next five years.

The full article appears in the April 2018 issue of Israel Today Magazine.
CLICK HERE to read it now >>


Not yet a subscriber to our digital magazine? Get an annual subscription now at only $20.99 for a limited time

Want more news from Israel?
Click Here to sign up for our FREE daily email updates

Current Issue

Get Your Israel Today App Now!

Your Vacation Apartment in Jerusalem

 

For Information & Reservations:

E-Mail: info@israeltoday.co.il

TEL.: +972-2-6226881

ADVERTISEMENTS